| Year |
Citation |
Score |
| 2020 |
Innes H, Buch S, Hutchinson S, Guha IN, Morling JR, Barnes E, Irving W, Forrest E, Pedergnan V, Goldberg D, Aspinall E, Barclay S, Hayes P, Dillon J, Nischalke HD, ... ... Morgan MY, et al. Genome-wide Association Study for Alcohol-related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1. Gastroenterology. PMID 32561361 DOI: 10.1053/J.Gastro.2020.06.014 |
0.352 |
|
| 2020 |
Ndiaye H, Liu J, Hall A, Minogue S, Morgan M, Waugh MG. Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases. Bioscience Reports. PMID 32286604 DOI: 10.1042/Bsr20200219 |
0.32 |
|
| 2020 |
Stickel F, Morgan MY. Predicting long-term prognosis in severe alcoholic hepatitis. Liver International : Official Journal of the International Association For the Study of the Liver. 40: 511-513. PMID 32124541 DOI: 10.1111/Liv.14343 |
0.353 |
|
| 2019 |
Stickel F, Lutz P, Buch S, Nischalke HD, Silva I, Rausch V, Fischer J, Weiss KH, Gotthardt D, Rosendahl J, Marot A, Elamly M, Krawczyk M, Casper M, Lammert F, ... ... Morgan MY, et al. Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers. Hepatology (Baltimore, Md.). PMID 31630428 DOI: 10.1002/Hep.30996 |
0.342 |
|
| 2019 |
Gluud LL, Jeyaraj R, Morgan MY. Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy. Journal of Clinical and Experimental Hepatology. 9: 354-361. PMID 31360028 DOI: 10.1016/J.Jceh.2019.02.004 |
0.314 |
|
| 2019 |
Argemi J, Latasa MU, Atkinson SR, Blokhin IO, Massey V, Gue JP, Cabezas J, Lozano JJ, Van Booven D, Bell A, Cao S, Vernetti LA, Arab JP, Ventura-Cots M, Edmunds LR, ... ... Morgan MY, et al. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. Nature Communications. 10: 3126. PMID 31311938 DOI: 10.1038/S41467-019-11004-3 |
0.406 |
|
| 2019 |
Zacharias HD, Zacharias AP, Gluud LL, Morgan MY. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis. The Cochrane Database of Systematic Reviews. 6: CD012334. PMID 31204790 DOI: 10.1002/14651858.Cd012334.Pub2 |
0.376 |
|
| 2019 |
Orlien SMS, Berhe NB, Morgan MY, Johannessen A. Khat-related liver disease in sub-Saharan Africa: neglected, yet important. The Lancet. Global Health. 7: e310. PMID 30784630 DOI: 10.1016/S2214-109X(18)30527-8 |
0.305 |
|
| 2019 |
Atkinson SR, Forrest E, Goh ET, Thursz MR, McQuillin A, Morgan MY. P: 81 Previously Identified Candidate Gene Associations in Hepatic Encephalopathy Do Not Replicate in the STOPAH Cohort The American Journal of Gastroenterology. 114. DOI: 10.14309/01.Ajg.0000582300.39254.Ab |
0.325 |
|
| 2019 |
Jackson CD, Marks M, Morgan MY. P: 80 Optimizing the Performance of the Psychometric Hepatic Encephalopathy Score (PHES) for the Diagnosis of Hepatic Encephalopathy American Journal of Gastroenterology. 114: S39-S39. DOI: 10.14309/01.Ajg.0000582296.62124.B1 |
0.361 |
|
| 2019 |
Jeyaraj R, Vadera S, Low ZY, Gluud LL, Morgan MY. P: 51 Aminoglycosides and Metronidazole for the Prevention and Treatment of Hepatic Encephalopathy in Adults With Cirrhosis The American Journal of Gastroenterology. 114. DOI: 10.14309/01.Ajg.0000582180.48663.4F |
0.339 |
|
| 2019 |
Sullivan L, Zakeri N, Negus R, Morgan MY. PTU-066 Management of helicobacter pylori infection in patients with upper GI bleeding: compliance with guidelines Gut. 68. DOI: 10.1136/Gutjnl-2019-Bsgabstracts.282 |
0.306 |
|
| 2019 |
Stickel F, Lutz P, Buch S, Rausch V, Silva I, Fischer J, Nischalke H, Rosendahl J, Krawczyk M, Casper M, Zopf S, Marhenke S, Lammert F, Vogel A, Datz C, ... ... Morgan M, et al. Carriage of HSD17B13 rs72613567TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis Zeitschrift Fur Gastroenterologie. 57. DOI: 10.1055/S-0038-1677104 |
0.362 |
|
| 2019 |
Stickel F, Lutz P, Buch S, Fischer J, Rausch V, Silva I, Rosendahl J, Nischalke HD, Krawczyk M, Lammert F, Casper M, Zopf S, Marhenke S, Vogel A, Eyer F, ... ... Morgan M, et al. PS-177-HSD17B13 rs72613567 TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis Journal of Hepatology. 70: e109-e110. DOI: 10.1016/S0618-8278(19)30195-1 |
0.357 |
|
| 2019 |
Thygesen JH, O'Brien N, Lydall GJ, Degenhardt F, Heilmann-Heimbach S, Bass N, Morgan MY, McQuillin A. An Alcohol Dependence Gwas On 2,650 Cases And >7,000 Controls From The United Kingdom European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.184 |
0.328 |
|
| 2018 |
Strnad P, Buch S, Hamesch K, Fischer J, Rosendahl J, Schmelz R, Brueckner S, Brosch M, Heimes CV, Woditsch V, Scholten D, Nischalke HD, Janciauskiene S, Mandorfer M, Trauner M, ... ... Morgan MY, et al. Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. Gut. PMID 30068662 DOI: 10.1136/Gutjnl-2018-316228 |
0.376 |
|
| 2018 |
Dhar P, Greenslade L, Westbrooke R, Jackson CD, Marshall A, Morgan MY. PWE-084 Relationship between indices of frailty/disability with disease severity and nutritional status in patients with cirrhosis Gut. 67. DOI: 10.1136/Gutjnl-2018-Bsgabstracts.226 |
0.318 |
|
| 2018 |
Hussain S, Zacharias H, Jackson C, Morgan M. PWE-083 The specificity of the electroencephalogram for diagnosing hepatic encephalopathy in patients with confounding comorbidities Gut. 67. DOI: 10.1136/Gutjnl-2018-Bsgabstracts.225 |
0.398 |
|
| 2018 |
Stickel F, Buch S, Rosendahl J, Nischalke H, Lammert F, Casper M, Vogel A, Deltenre P, Eyer F, Gotthardt D, Berg T, Hampe J, Morgan MY. OWE-016 Genetic variants in PNPLA3 and TM6SF2 predispose to hepatocellular carcinoma in patients with alcohol-related cirrhosis Gut. 67. DOI: 10.1136/Gutjnl-2018-Bsgabstracts.209 |
0.32 |
|
| 2018 |
Strnad P, Buch S, Hamesch K, Fischer J, Heimes C, Gutberlet M, Janciauskiene S, Mandorfer M, Trauner M, Reichert M, Krawczyk M, Lammert F, Deltenre P, Schafmayer C, Nothnagel M, ... ... Morgan M, et al. Heterozygous carriage of the alpha1-antitrypsin PiZ variant increases the risk to develop liver fibrosis Zeitschrift Fur Gastroenterologie. 56. DOI: 10.1055/S-0037-1612696 |
0.305 |
|
| 2017 |
Goh ET, Andersen ML, Morgan MY, Gluud LL. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. The Cochrane Database of Systematic Reviews. 8: CD002798. PMID 28796283 DOI: 10.1002/14651858.Cd002798.Pub4 |
0.367 |
|
| 2017 |
Way MJ, Ali MA, McQuillin A, Morgan MY. Genetic variants in ALDH1B1 and alcohol dependence risk in a British and Irish population: A bioinformatic and genetic study. Plos One. 12: e0177009. PMID 28594837 DOI: 10.1371/Journal.Pone.0177009 |
0.317 |
|
| 2017 |
McCabe WA, Way MJ, Ruparelia K, Knapp S, Ali MA, Anstee QM, Thomas HC, McQuillin A, Morgan MY. Genetic variation in GABRβ1 and the risk for developing alcohol dependence. Psychiatric Genetics. PMID 28346242 DOI: 10.1097/Ypg.0000000000000169 |
0.319 |
|
| 2017 |
Goh ET, Morgan MY. Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore. Alimentary Pharmacology & Therapeutics. PMID 28220511 DOI: 10.1111/Apt.13965 |
0.315 |
|
| 2017 |
Olesen SS, Jackson CD, Morgan MY. Tools and tactics for improving diagnosis of hepatic encephalopathy. Journal of Hepatology. PMID 28215598 DOI: 10.1016/J.Jhep.2017.01.034 |
0.335 |
|
| 2017 |
Atkinson SR, Way MJ, McQuillin A, Morgan MY, Thursz MR. Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis. Journal of Hepatology. PMID 28161471 DOI: 10.1016/J.Jhep.2017.01.018 |
0.38 |
|
| 2017 |
Zacharias HD, Jackson CD, Morgan MY, Olesen SS. Letter: stepwise diagnosis in covert hepatic encephalopathy - critical flicker frequency and MELD-score as a first-step approach. Replication and pitfalls. Alimentary Pharmacology & Therapeutics. 45: 187-189. PMID 27910151 DOI: 10.1111/Apt.13830 |
0.309 |
|
| 2017 |
Morgan MY. S18-3ALCOHOL WITHDRAWAL AND HEPATIC ENCEPHALOPATHY IN PEOPLE WITH CIRRHOSIS–A THERAPEUTIC DILEMMA Alcohol and Alcoholism. 52: i4-i30. DOI: 10.1093/Alcalc/Agx075.68 |
0.375 |
|
| 2017 |
Atkinson SR, Forlano R, Manousou P, Grove J, Aithal G, McQuillin A, Quaglia A, Thursz MR, Goldin R, Morgan MY. OR4-2CARRIAGE OF RS738409 IN PNPLA3 IS POSITIVELY ASSOCIATED WITH THE SEVERITY OF HISTOLOGICAL DAMAGE IN PATIENTS WITH ALCOHOLIC HEPATITIS Alcohol and Alcoholism. 52: i31-i49. DOI: 10.1093/Alcalc/Agx074.39 |
0.403 |
|
| 2017 |
Morgan MY. PL5ALCOHOL-RELATED LIVER DISEASE AND ITS NEUROLOGICAL COMORBIDITIES –IS IT ALL IN THE GENES Alcohol and Alcoholism. 52: i1-i3. DOI: 10.1093/Alcalc/Agx073.05 |
0.315 |
|
| 2017 |
Strnad P, Buch S, Hamesch K, Rosendahl J, Fischer J, Nischalke H, Spivak I, Janciauskiene S, Mandorfer M, Trauner M, Sipos B, Schafmayer C, Aigner E, Datz C, Stickel F, ... Morgan M, et al. Heterozygous carriage of the alpha1-antitrypsin Z variant rs28929474 predisposes to the development of cirrhosis in the presence of alcohol misuse and non-alcohol-related fatty liver disease Journal of Hepatology. 66: S177. DOI: 10.1016/S0168-8278(17)30638-4 |
0.371 |
|
| 2017 |
Stickel F, Buch S, Janet F, Rosendahl J, Morgan M, Nischalke H, Lammert F, Casper M, Zopf S, Marhenke S, Vogel A, Deltenre P, Eyer F, Felden J, Gotthardt D, et al. Genetic variation of PNPLA3 and TM6SF2 associate with hepatocellular carcinoma in patients with alcohol-related cirrhosis Journal of Hepatology. 66: S174. DOI: 10.1016/S0168-8278(17)30630-X |
0.355 |
|
| 2017 |
Atkinson S, Way M, McQuillin A, Morgan M, Thursz M. Drinking behaviour and rs738409:G in PNPLA3 are associated with slower recovery of liver function following severe alcoholic hepatitis Journal of Hepatology. 66: S116-S117. DOI: 10.1016/S0168-8278(17)30495-6 |
0.396 |
|
| 2017 |
Kimer N, Gluud L, Morris R, Morgan M. Rifaximin for the prevention and treatment of hepatic encephalopathy: a systematic review with meta-analyses of randomised controlled trials Journal of Hepatology. 66: S561-S562. DOI: 10.1016/J.Jceh.2017.01.105 |
0.301 |
|
| 2017 |
Zacharias H, Jackson C, Drewes A, Morgan M, Olesen S. Functional cortical connectivity is disturbed in patients with cirrhosis even when neuropsychometric performance is unimpaired Journal of Hepatology. 66: S393. DOI: 10.1016/J.Jceh.2017.01.091 |
0.319 |
|
| 2017 |
Zacharias H, Jackson CD, Patch D, Westbrook RH, Greenslade L, Morgan MY. Derivation of Decision Algorithms for the Diagnosis of Hepatic Encephalopathy in Patients With Cirrhosis Journal of Clinical and Experimental Hepatology. 7: S14. DOI: 10.1016/J.Jceh.2017.01.019 |
0.344 |
|
| 2017 |
Jeyaraj R, Morgan MY, Gluud LL. Aminoglycosides and metronidazole for people with cirrhosis and hepatic encephalopathy Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd012734 |
0.378 |
|
| 2016 |
Balasus D, Way M, Fusilli C, Mazza T, Morgan MY, Cervello M, Giannitrapani L, Soresi M, Agliastro R, Vinciguerra M, Montalto G. The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population. Oncotarget. PMID 27888630 DOI: 10.18632/Oncotarget.13558 |
0.315 |
|
| 2016 |
Morgan MY. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides. Metabolic Brain Disease. PMID 27638474 DOI: 10.1007/S11011-016-9910-2 |
0.395 |
|
| 2016 |
Stickel F, Moreno C, Hampe J, Morgan MY. The Genetics of Alcohol Dependence and Alcohol-related Liver Disease. Journal of Hepatology. PMID 27575312 DOI: 10.1016/J.Jhep.2016.08.011 |
0.363 |
|
| 2016 |
Grover VP, McPhail MJ, Wylezinska-Arridge M, Crossey MM, Fitzpatrick JA, Southern L, Saxby BK, Cook NA, Cox IJ, Waldman AD, Dhanjal NS, Bak-Bol A, Williams R, Morgan MY, Taylor-Robinson SD. A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy. Metabolic Brain Disease. PMID 27488112 DOI: 10.1007/S11011-016-9881-3 |
0.303 |
|
| 2016 |
Jackson CD, Gram M, Halliday E, Olesen SS, Sandberg TH, Drewes AM, Morgan MY. New spectral thresholds improve the utility of the electroencephalogram for the diagnosis of hepatic encephalopathy. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. PMID 27236607 DOI: 10.1016/J.Clinph.2016.03.027 |
0.315 |
|
| 2016 |
Olesen SS, Gram M, Jackson CD, Halliday E, Sandberg TH, Drewes AM, Morgan MY. Electroencephalogram variability in patients with cirrhosis associates with the presence and severity of hepatic encephalopathy. Journal of Hepatology. PMID 27184531 DOI: 10.1016/J.Jhep.2016.05.004 |
0.373 |
|
| 2016 |
Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. The Cochrane Database of Systematic Reviews. 5: CD003044. PMID 27153247 DOI: 10.1002/14651858.Cd003044.Pub4 |
0.333 |
|
| 2016 |
Gluud LL, Vilstrup H, Morgan MY. Non-Absorbable Disaccharides for Hepatic Encephalopathy: A Systematic Review and Meta-Analysis. Hepatology (Baltimore, Md.). PMID 27081787 DOI: 10.1002/Hep.28598 |
0.342 |
|
| 2016 |
Atkinson S, Way M, McQuillin A, Morgan M, Thursz M. OC-031 A Genome-Wide Association Study Identifies PNPLA3 and SLC38A4 as Risk Loci for Alcoholic Hepatitis Gut. 65. DOI: 10.1136/Gutjnl-2016-312388.31 |
0.408 |
|
| 2016 |
Goh E, Way M, Atkinson S, McQuillin A, Morgan M. PWE-033 Promoter Region Variations in The Glutaminase Gene as A Risk Factor for The Development Hepatic Encephalopathy in Patients with Cirrhosis: Abstract PWE-033 Table 1 Gut. 65: A155.1-A155. DOI: 10.1136/Gutjnl-2016-312388.279 |
0.394 |
|
| 2016 |
Fennessy C, Kimer N, Morgan M. SUN-P139: Assessment of Resting Energy Expenditure in Patients with Cirrhosis Remains Problematic Clinical Nutrition. 35: S95. DOI: 10.1016/S0261-5614(16)30482-4 |
0.324 |
|
| 2016 |
Atkinson S, Way M, McQuillin A, Morgan M, Thursz M. A Genome-Wide Association Study Identifies PNPLA3 and SLC38A4 as Risk Loci for Alcoholic Hepatitis Journal of Hepatology. 64: S134. DOI: 10.1016/S0168-8278(16)01634-2 |
0.352 |
|
| 2016 |
Goh E, Way M, Atkinson S, McQuillin A, Morgan M. Variations in the Promoter Region of the Glutaminase Gene and the Development of Hepatic Encephalopathy in Patients with Cirrhosis Journal of Hepatology. 64: S257. DOI: 10.1016/S0168-8278(16)00283-X |
0.379 |
|
| 2016 |
Zacharias HD, Zacharias AP, Oliveira Ferreira A, Morgan MY, Gluud LL. Ammonia scavenging agents for people with cirrhosis and hepatic encephalopathy Cochrane Database of Systematic Reviews. 2016. DOI: 10.1002/14651858.Cd012334 |
0.321 |
|
| 2015 |
Morgan MY. Acute alcohol toxicity and withdrawal in the emergency room and medical admissions unit. Clinical Medicine (London, England). 15: 486-9. PMID 26430192 DOI: 10.7861/Clinmedicine.15-5-486 |
0.309 |
|
| 2015 |
Morgan MY, Amodio P, Cook NA, Jackson CD, Kircheis G, Lauridsen MM, Montagnese S, Schiff S, Weissenborn K. Qualifying and quantifying minimal hepatic encephalopathy. Metabolic Brain Disease. PMID 26412229 DOI: 10.1007/S11011-015-9726-5 |
0.685 |
|
| 2015 |
Ali MA, Way MJ, Marks M, Guerrini I, Thomson AD, Strang J, McQuillin A, Morgan MY. Phenotypic heterogeneity in study populations may significantly confound the results of genetic association studies on alcohol dependence. Psychiatric Genetics. 25: 234-40. PMID 26368818 DOI: 10.1097/Ypg.0000000000000105 |
0.339 |
|
| 2015 |
Grover VP, Crossey MM, Fitzpatrick JA, Saxby BK, Shaw R, Waldman AD, Morgan MY, Taylor-Robinson SD. Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study. Metabolic Brain Disease. PMID 26251205 DOI: 10.1007/S11011-015-9716-7 |
0.39 |
|
| 2015 |
Stevenson M, Pandor A, Stevens JW, Rawdin A, Rice P, Thompson J, Morgan MY. Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. PMID 25851485 DOI: 10.1007/S40273-015-0272-0 |
0.307 |
|
| 2015 |
Montagnese S, Middleton B, Corrias M, Mani AR, Skene DJ, Morgan MY. Assessment of 6-sulfatoxymelatonin rhythms and melatonin response to light in disease states: lessons from cirrhosis. Chronobiology International. 32: 187-94. PMID 25264562 DOI: 10.3109/07420528.2014.961607 |
0.688 |
|
| 2015 |
Morgan MY. SY04-2THE GENETICS OF ALCOHOL DEPENDENCE AND ALCOHOLIC LIVER DISEASE Alcohol and Alcoholism. 50: i5.4-i6. DOI: 10.1093/Alcalc/Agv076.14 |
0.353 |
|
| 2015 |
Way M, Atkinson S, McQuillin A, Thursz M, Morgan M. P1123 : A functional variant in TM6SF2 associates with alcohol-related cirrhosis risk in a British and Irish population Journal of Hepatology. 62: S772. DOI: 10.1016/S0168-8278(15)31320-9 |
0.333 |
|
| 2015 |
Gluud L, Vilstrup H, Morgan M. P0138 : The effect of treatment for hepatic encephalopathy with nonabsorbable disaccharides on morbidity and mortality in patients with cirrhosis: Systematic review and meta-analyses Journal of Hepatology. 62: S353. DOI: 10.1016/S0168-8278(15)30358-5 |
0.361 |
|
| 2015 |
Buch S, Stickel F, Trépo E, Way M, Herrmann A, Nischalke H, Brosch M, Rosendahl J, Berg T, Fischer J, Ridinger M, Rietschel M, McQuillin A, Frank J, Kiefer F, ... ... Morgan M, et al. LO6 : A two-stage genome-wide association study identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis Journal of Hepatology. 62: S260-S261. DOI: 10.1016/S0168-8278(15)30152-5 |
0.358 |
|
| 2013 |
Anstee QM, Knapp S, Maguire EP, Hosie AM, Thomas P, Mortensen M, Bhome R, Martinez A, Walker SE, Dixon CI, Ruparelia K, Montagnese S, Kuo YT, Herlihy A, Bell JD, ... ... Morgan MY, et al. Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibition. Nature Communications. 4: 2816. PMID 24281383 DOI: 10.1038/Ncomms3816 |
0.541 |
|
| 2013 |
Amodio P, Bemeur C, Butterworth R, Cordoba J, Kato A, Montagnese S, Uribe M, Vilstrup H, Morgan MY. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology (Baltimore, Md.). 58: 325-36. PMID 23471642 DOI: 10.1002/Hep.26370 |
0.655 |
|
| 2013 |
Dissanayake OM, Young A, Morgan M, MacNaughtan J, Patch D. PWE-123 Predictors Of Hepatic Encephalopathy and Mortality Following Tips Insertion for Refractory Ascites Gut. 62: A180.3-A181. DOI: 10.1136/Gutjnl-2013-304907.411 |
0.348 |
|
| 2013 |
Way M, McQuillin A, Gurling H, Morgan M. 1405 THE ZNF699 GENE IS NOT ASSOCIATED WITH ALCOHOL DEPENDENCE IN A UK SAMPLE BUT MAY ALTER RISK FOR ALCOHOL-RELATED CIRRHOSIS Journal of Hepatology. 58: S564. DOI: 10.1016/S0168-8278(13)61404-X |
0.33 |
|
| 2013 |
Way M, McQuillin A, Gurling H, Morgan M. 1404 THE PNPA3 I148M MUTATION SIGNIFICANTLY INCREASES THE RISK OF DEVELOPING ALCOHOL-RELATED CIRRHOSIS IN ALCOHOL DEPENDENT INDIVIDUALS Journal of Hepatology. 58: S563-S564. DOI: 10.1016/S0168-8278(13)61403-8 |
0.325 |
|
| 2013 |
Dissanayake O, MacNaughton J, Patch D, Morgan M. 1022 HEPATIC ENCEPHALOPATHY IS A SIGNIFICANT PREDICTOR OF MORTALITY FOLLOWING TIPS INSERTION FOR REFRACTORY ASCITES Journal of Hepatology. 58: S420-S421. DOI: 10.1016/S0168-8278(13)61023-5 |
0.332 |
|
| 2012 |
Stevenson M, Lloyd-Jones M, Morgan MY, Wong R. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation. Health Technology Assessment (Winchester, England). 16: 1-174. PMID 22333291 DOI: 10.3310/Hta16040 |
0.416 |
|
| 2012 |
Williams E, Herren M, Jackson C, Pflugrad H, Krause J, Weber L, Weissenborn K, Morgan M. 910 ABNORMAL EEG ACTIVITY IN PATIENTS WITH CHRONIC HEPATITIS C (HCV) INFECTION AND MINIMAL LIVER DISEASE Journal of Hepatology. 56: S354. DOI: 10.1016/S0168-8278(12)60922-2 |
0.376 |
|
| 2011 |
Lydall GJ, Saini J, Ruparelia K, Montagnese S, McQuillin A, Guerrini I, Rao H, Reynolds G, Ball D, Smith I, Thomson AD, Morgan MY, Gurling HM. Genetic association study of GABRA2 single nucleotide polymorphisms and electroencephalography in alcohol dependence. Neuroscience Letters. 500: 162-6. PMID 21683760 DOI: 10.1016/J.Neulet.2011.05.240 |
0.571 |
|
| 2011 |
Stubbs MA, Morgan MY. Managing alcohol dependence and alcohol-related liver disease: a problem for the hepatologist, psychiatrist or economist? Clinical Medicine (London, England). 11: 189-93. PMID 21526709 DOI: 10.7861/Clinmedicine.11-2-189 |
0.339 |
|
| 2011 |
Bajaj JS, Cordoba J, Mullen KD, Amodio P, Shawcross DL, Butterworth RF, Morgan MY. Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Alimentary Pharmacology & Therapeutics. 33: 739-47. PMID 21306407 DOI: 10.1111/J.1365-2036.2011.04590.X |
0.58 |
|
| 2011 |
Montagnese S, Middleton B, Mani AR, Skene DJ, Morgan MY. Changes in the 24-h plasma cortisol rhythm in patients with cirrhosis. Journal of Hepatology. 54: 588-90; author reply. PMID 21134700 DOI: 10.1016/J.Jhep.2010.08.015 |
0.688 |
|
| 2011 |
Korth-Bradley JM, Baird-Bellaire SJ, Patat AA, Troy SM, Böhmer GM, Gleiter CH, Buecheler R, Morgan MY. Pharmacokinetics and safety of a single intravenous dose of the antibiotic tigecycline in patients with cirrhosis. Journal of Clinical Pharmacology. 51: 93-101. PMID 20308689 DOI: 10.1177/0091270010363477 |
0.362 |
|
| 2011 |
Halliday E, Stevens S, Stubbs M, Morris R, Morgan M. P13 The performance validity of breath sample analysis in the diagnosis of hepatic encephalopathy in patients with cirrhosis Gut. 60: A6-A7. DOI: 10.1136/Gutjnl-2011-300857A.13 |
0.43 |
|
| 2011 |
Morgan MY. Hepatic Encephalopathy in Patients with Cirrhosis Sherlock's Diseases of the Liver and Biliary System, 12th Edition. 121-151. DOI: 10.1002/9781119237662.Ch10 |
0.443 |
|
| 2010 |
Montagnese S, Middleton B, Mani AR, Skene DJ, Morgan MY. On the origin and the consequences of circadian abnormalities in patients with cirrhosis. The American Journal of Gastroenterology. 105: 1773-81. PMID 20332771 DOI: 10.1038/Ajg.2010.86 |
0.706 |
|
| 2010 |
Kajihara M, Montagnese S, Khanna P, Amodio P, Schapira AH, Dusheiko GM, Morgan MY. Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two cases. European Journal of Gastroenterology & Hepatology. 22: 628-31. PMID 20075741 DOI: 10.1097/Meg.0B013E32833383E3 |
0.661 |
|
| 2010 |
Montagnese S, Middleton B, Mani AR, Skene DJ, Morgan MY. Melatonin rhythms in patients with cirrhosis. The American Journal of Gastroenterology. 105: 220-2; author reply . PMID 20054310 DOI: 10.1038/Ajg.2009.549 |
0.709 |
|
| 2010 |
Montagnese S, Schiff S, Gatta A, Riggio O, Morgan MY, Amodio P. Hepatic encephalopathy: you should only comment on what you have actually measured. Journal of Gastroenterology. 45: 342-3; author reply . PMID 19997943 DOI: 10.1007/S00535-009-0171-2 |
0.667 |
|
| 2010 |
Morgan M, Stubbs M, Dabrowski H, Jackson C. P29 Do disturbances in cerebral oscillatory networks explain sleep and neuropsychiatric abnormalities in patients with cirrhosis Gut. 59. DOI: 10.1136/Gut.2010.223362.55 |
0.338 |
|
| 2010 |
Morgan M, Dabrowski H, Stubbs M, Jackson C. P28 Optimising the analysis of the electroencephalogram in hepatic encephalopathy Gut. 59. DOI: 10.1136/Gut.2010.223362.54 |
0.336 |
|
| 2010 |
Hussein M, Goh Y, Youl B, Jackson CD, Morgan MY. OC-034 The diagnosis of hepatic encephalopathy: test performance of novel paradigms: Abstract OC-034 Gut. 59: A14.2-A14. DOI: 10.1136/Gut.2009.208959H |
0.357 |
|
| 2009 |
Montagnese S, Middleton B, Mani AR, Skene DJ, Morgan MY. Sleep and circadian abnormalities in patients with cirrhosis: features of delayed sleep phase syndrome? Metabolic Brain Disease. 24: 427-39. PMID 19756996 DOI: 10.1007/S11011-009-9146-5 |
0.689 |
|
| 2009 |
Montagnese S, Middleton B, Skene DJ, Morgan MY. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis. Liver International : Official Journal of the International Association For the Study of the Liver. 29: 1372-82. PMID 19686311 DOI: 10.1111/J.1478-3231.2009.02089.X |
0.592 |
|
| 2009 |
Montagnese S, Middleton B, Skene DJ, Morgan MY. Sleep-wake patterns in patients with cirrhosis: all you need to know on a single sheet. A simple sleep questionnaire for clinical use. Journal of Hepatology. 51: 690-5. PMID 19664835 DOI: 10.1016/J.Jhep.2009.06.006 |
0.539 |
|
| 2009 |
Mani AR, Montagnese S, Jackson CD, Jenkins CW, Head IM, Stephens RC, Moore KP, Morgan MY. Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy. American Journal of Physiology. Gastrointestinal and Liver Physiology. 296: G330-8. PMID 19023029 DOI: 10.1152/Ajpgi.90488.2008 |
0.769 |
|
| 2009 |
Montagnese S, Middleton B, Mani A, Skene D, Morgan M. 206 HEPATO-ADRENAL SYNDROME: DOES CORTISOL SAMPLE TIME MATTER? Journal of Hepatology. 50: S84. DOI: 10.1016/S0168-8278(09)60208-7 |
0.64 |
|
| 2008 |
Marks M, Jackson C, Montagnese S, Jenkins C, Head M, Morris R, Morgan M. 300 DERIVATION OF A NORMATIVE UK DATABASE FOR THE PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE (PHES): CONFOUNDING EFFECT OF ETHNICITY AND TEST SCORING Journal of Hepatology. 48: S119. DOI: 10.1016/S0168-8278(08)60302-5 |
0.556 |
|
| 2008 |
Montagnese S, Middleton B, Skene D, Morgan M. 92 SLEEP DISTURBANCES ARE NOT A FEATURE OF HEPATIC ENCEPHALOPATHY Journal of Hepatology. 48: S40. DOI: 10.1016/S0168-8278(08)60094-X |
0.554 |
|
| 2007 |
Mullen KD, Amodio P, Morgan MY. Therapeutic studies in hepatic encephalopathy. Metabolic Brain Disease. 22: 407-23. PMID 17885745 DOI: 10.1007/S11011-007-9061-6 |
0.542 |
|
| 2007 |
Morgan MY, Blei A, Grüngreiff K, Jalan R, Kircheis G, Marchesini G, Riggio O, Weissenborn K. The treatment of hepatic encephalopathy. Metabolic Brain Disease. 22: 389-405. PMID 17846875 DOI: 10.1007/S11011-007-9060-7 |
0.365 |
|
| 2007 |
Montagnese S, Jackson C, Morgan MY. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis. Journal of Hepatology. 46: 447-58. PMID 17239476 DOI: 10.1016/J.Jhep.2006.10.015 |
0.598 |
|
| 2006 |
Morgan MY, Madden AM, Jennings G, Elia M, Fuller NJ. Two-component models are of limited value for the assessment of body composition in patients with cirrhosis. The American Journal of Clinical Nutrition. 84: 1151-62. PMID 17093169 DOI: 10.1093/Ajcn/84.5.1151 |
0.32 |
|
| 2006 |
Montagnese S, Middleton B, Mani A, Skene D, Morgan M. 746 Evidence of central circadian disruption in patients with cirrhosis Journal of Hepatology. 44: S276. DOI: 10.1016/S0168-8278(06)80747-6 |
0.714 |
|
| 2006 |
Montagnese S, Jackson C, Morgan M. P04.2 Topographical changes in the electroencephalogram (EEG) in patients with cirrhosis Clinical Neurophysiology. 117: 138. DOI: 10.1016/J.Clinph.2006.06.219 |
0.573 |
|
| 2005 |
Montagnese S, Gordon HM, Jackson C, Smith J, Tognella P, Jethwa N, Sherratt RM, Morgan MY. Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment. Hepatology (Baltimore, Md.). 42: 772-81. PMID 16175619 DOI: 10.1002/Hep.20855 |
0.624 |
|
| 2005 |
Morgan MY, Amodio P. Treatment for hepatic encephalopathy: tips from TIPS? Journal of Hepatology. 42: 626-8. PMID 15826708 DOI: 10.1016/J.Jhep.2005.03.001 |
0.552 |
|
| 2004 |
Montagnese S, Amodio P, Morgan MY. Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach. Metabolic Brain Disease. 19: 281-312. PMID 15554423 DOI: 10.1023/B:Mebr.0000043977.11113.2A |
0.65 |
|
| 2004 |
Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metabolic Brain Disease. 19: 253-67. PMID 15554421 DOI: 10.1023/B:Mebr.0000043975.01841.De |
0.654 |
|
| 2004 |
Morgan MY, Landron F, Lehert P. Improvement in quality of life after treatment for alcohol dependence with acamprosate and psychosocial support. Alcoholism, Clinical and Experimental Research. 28: 64-77. PMID 14745303 DOI: 10.1097/01.Alc.0000108652.73143.4B |
0.328 |
|
| 2002 |
Pelc I, Ansoms C, Lehert P, Fischer F, Fuchs WJ, Landron F, Pires Preto AJ, Morgan MY. The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction. Alcoholism, Clinical and Experimental Research. 26: 1529-38. PMID 12394286 DOI: 10.1111/J.1530-0277.2002.Tb02452.X |
0.345 |
|
| 2000 |
Marshall JC, Lample F, Gordon HM, Madden AM, Morgan MY. Seroprevalence of Helicobacter pylori(HP)is influenced by alcohol consumption and severity of liver injury Gastroenterology. 118: A1270. DOI: 10.1016/S0016-5085(00)80928-2 |
0.343 |
|
| 1999 |
Madden AM, Morgan MY. Patterns of energy intake in patients with cirrhosis and healthy volunteers. The British Journal of Nutrition. 82: 41-8. PMID 10655955 DOI: 10.1017/S0007114599001105 |
0.305 |
|
| 1999 |
Soulsby CT, Morgan MY. Dietary management of hepatic encephalopathy in cirrhotic patients: survey of current practice in United Kingdom. Bmj (Clinical Research Ed.). 318: 1391. PMID 10334749 DOI: 10.1136/Bmj.318.7195.1391 |
0.381 |
|
| 1998 |
Morgan MY. Cerebral magnetic resonance imaging in patients with chronic liver disease. Metabolic Brain Disease. 13: 273-90. PMID 10206820 DOI: 10.1023/A:1020680624084 |
0.337 |
|
| 1997 |
Madden AM, Bradbury W, Morgan MY. Taste perception in cirrhosis: its relationship to circulating micronutrients and food preferences. Hepatology (Baltimore, Md.). 26: 40-8. PMID 9214450 DOI: 10.1002/Hep.510260106 |
0.302 |
|
| 1996 |
Morgan MY. Noninvasive neuroinvestigation in liver disease. Seminars in Liver Disease. 16: 293-314. PMID 8989815 DOI: 10.1055/S-2007-1007242 |
0.372 |
|
| 1996 |
Levine JA, Morgan MY. Weighed dietary intakes in patients with chronic liver disease. Nutrition (Burbank, Los Angeles County, Calif.). 12: 430-5. PMID 8875538 DOI: 10.1016/S0899-9007(96)00098-6 |
0.411 |
|
| 1996 |
Morgan MY. The treatment of alcoholic hepatitis. Alcohol and Alcoholism (Oxford, Oxfordshire). 31: 117-34. PMID 8737007 DOI: 10.1093/Oxfordjournals.Alcalc.A008123 |
0.425 |
|
| 1995 |
Morgan MY. The management of alcohol withdrawal using chlormethiazole. Alcohol and Alcoholism (Oxford, Oxfordshire). 30: 771-4. PMID 8679018 DOI: 10.1093/Oxfordjournals.Alcalc.A045795 |
0.319 |
|
| 1995 |
Menon DK, Harris M, Sargentoni J, Taylor-Robinson SD, Cox IJ, Morgan MY. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers. Gastroenterology. 108: 776-88. PMID 7875480 DOI: 10.1016/0016-5085(95)90451-4 |
0.418 |
|
| 1995 |
Menon DK, Sargentoni J, Taylor-robinson SD, Bell JD, Cox IJ, Bryant DJ, Coutts GA, Rolles K, Burroughs AK, Morgan MY. Other clinical studyEffect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: Biochemical basis of spectral appearances☆ Hepatology. 21. DOI: 10.1016/0270-9139(95)90102-7 |
0.42 |
|
| 1994 |
Taylor-Robinson SD, Sargentoni J, Mallalieu RJ, Bell JD, Bryant DJ, Coutts GA, Morgan MY. Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology (Baltimore, Md.). 20: 1173-8. PMID 7927249 DOI: 10.1002/Hep.1840200511 |
0.36 |
|
| 1994 |
Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metabolic Brain Disease. 9: 347-59. PMID 7898401 DOI: 10.1007/Bf02098881 |
0.331 |
|
| 1994 |
Madden AM, Morgan MY. A comparison of skinfold anthropometry and bioelectrical impedance analysis for measuring percentage body fat in patients with cirrhosis. Journal of Hepatology. 21: 878-83. PMID 7890906 DOI: 10.1016/S0168-8278(94)80253-X |
0.324 |
|
| 1993 |
Taylor-Robinson S, Bell J, Sargentoni J, Bryant D, Mallalieu R, Morgan M. Cerebral 31P Mrs in Patients with Chronic Hepatic Encephalopathy Clinical Science. 85: 14P-14P. DOI: 10.1042/Cs085014Pc |
0.383 |
|
| 1992 |
McCormick PA, Morgan MY, Phillips A, Yin TP, McIntyre N, Burroughs AK. The effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal haemorrhage. Journal of Hepatology. 14: 99-103. PMID 1737922 DOI: 10.1016/0168-8278(92)90137-E |
0.345 |
|
| 1991 |
Menon D, Harris M, Sargentoni J, Cox I, Morgan M. Hepatic Phosphorus-31 Magnetic Resonance Spectroscopy (31P MRS) in Patients with Alcoholic Cirrhosis Clinical Science. 80: 17P-17P. DOI: 10.1042/Cs080017Pa |
0.383 |
|
| 1991 |
Morgan M, Menon D, Harris M, Sargentoni J, Cox I. Hepatic Phosphorus-31 Magnetic Resonance Spectroscopy (31P MRS) in Individuals Chronically Abusing Alcohol Clinical Science. 80: 2P-2P. DOI: 10.1042/Cs080002Pa |
0.339 |
|
| 1991 |
Morgan M, Cox I, Harris M, Sargentoni J, Menon D. Hepatic phosphorus-31 magnetic resonance spectroscopy (31P MRS) in alcohol abusers Journal of Hepatology. 13: S149. DOI: 10.1016/0168-8278(91)91568-2 |
0.332 |
|
| 1991 |
Morgan M, Menon D, Harris M, Sargentoni J, Cox I. Hepatic phosphorus-31 magnetic resonance spectroscopy(31P MRS) in alcoholic cirrhosis Journal of Hepatology. 13: S149. DOI: 10.1016/0168-8278(91)91567-Z |
0.35 |
|
| 1990 |
Morgan MY. Branched chain amino acids in the management of chronic liver disease. Facts and fantasies. Journal of Hepatology. 11: 133-41. PMID 2254623 DOI: 10.1016/0168-8278(90)90103-X |
0.317 |
|
| 1990 |
Morgan MY, Stambuk D, Cottrell J, Mann SG. Pharmacokinetics of famotidine in normal subjects and in patients with chronic liver disease. Alimentary Pharmacology & Therapeutics. 4: 83-96. PMID 2104076 DOI: 10.1111/J.1365-2036.1990.Tb00452.X |
0.336 |
|
| 1990 |
Morgan MY, Crespo DM, Jacobs RS, Philips A, Dusheiko G. The prevalence of antibody to hepatitis C in patients with liver disease in Great Britain and the risk factors associated with its presence Journal of Hepatology. 11: S104. DOI: 10.1016/0168-8278(90)91747-K |
0.37 |
|
| 1989 |
Morgan MY, Alonso M, Stanger LC. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study. Journal of Hepatology. 8: 208-17. PMID 2654285 DOI: 10.1016/0168-8278(89)90009-3 |
0.388 |
|
| 1989 |
Norton RN, Morgan MY. Improving information on the role of alcohol in interpersonal violence in Great Britain. Alcohol and Alcoholism (Oxford, Oxfordshire). 24: 577-89. PMID 2627246 DOI: 10.1093/Oxfordjournals.Alcalc.A044961 |
0.314 |
|
| 1989 |
Norton RN, Morgan MY. The role of alcohol in mortality and morbidity from interpersonal violence. Alcohol and Alcoholism (Oxford, Oxfordshire). 24: 565-76. PMID 2627245 DOI: 10.1093/Oxfordjournals.Alcalc.A044960 |
0.317 |
|
| 1988 |
Scott NR, Stambuk D, Chakraborty J, Marks V, Morgan MY. Caffeine clearance and biotransformation in patients with chronic liver disease. Clinical Science (London, England : 1979). 74: 377-84. PMID 3356110 DOI: 10.1042/Cs0740377 |
0.337 |
|
| 1987 |
Morgan MY, Hawley KE, Stambuk D. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study. Journal of Hepatology. 4: 236-44. PMID 3295020 DOI: 10.1016/S0168-8278(87)80086-7 |
0.329 |
|
| 1986 |
Hawley KE, Morgan MY. Alcholic liver disease Current Opinion in Gastroenterology. 2: 340-350. DOI: 10.1097/00001574-198605000-00004 |
0.329 |
|
| 1985 |
Kibbler CC, Cohen DL, Cruicshank JK, Kushwaha SS, Morgan MY, Dick RD. Use of CAT scanning in the diagnosis and management of hepatic artery aneurysm. Gut. 26: 752-6. PMID 4018639 DOI: 10.1136/Gut.26.7.752 |
0.31 |
|
| 1985 |
Morgan MY. Hepatoprotective agents in alcoholic liver disease. Acta Medica Scandinavica. Supplementum. 703: 225-33. PMID 3937442 DOI: 10.1111/J.0954-6820.1985.Tb08919.X |
0.366 |
|
| 1985 |
Hawley KE, Morgan MY. Nutrition and the liver Current Opinion in Gastroenterology. 1: 409-417. DOI: 10.1097/00001574-198505000-00006 |
0.349 |
|
| 1984 |
Lanthier PL, Reshef R, Shah RR, Oates NS, Smith RL, Morgan MY. Oxidation phenotyping in alcoholics with liver disease of varying severity. Alcoholism, Clinical and Experimental Research. 8: 435-41. PMID 6391252 DOI: 10.1111/J.1530-0277.1984.Tb05697.X |
0.406 |
|
| 1983 |
Chapman RW, Morgan MY, Bell R, Sherlock S. Hepatic iron uptake in alcoholic liver disease. Gastroenterology. 84: 143-7. PMID 6847841 DOI: 10.1016/S0016-5085(83)80178-4 |
0.398 |
|
| 1983 |
Chapman RW, Morgan MY, Boss AM, Sherlock S. Acute and chronic effects of alcohol on iron absorption. Digestive Diseases and Sciences. 28: 321-7. PMID 6831996 DOI: 10.1007/Bf01324948 |
0.318 |
|
| 1982 |
Morgan MY, Marshall AW, Milsom JP, Sherlock S. Plasma amino-acid patterns in liver disease. Gut. 23: 362-70. PMID 7076013 |
0.315 |
|
| 1982 |
Marshall AW, Jakobovits AW, Morgan MY. Bromocriptine-associated hyponatraemia in cirrhosis. British Medical Journal (Clinical Research Ed.). 285: 1534-5. PMID 6814633 DOI: 10.1136/Bmj.285.6354.1534 |
0.305 |
|
| 1982 |
Marshall AW, Graul RS, Morgan MY, Sherlock S. Treatment of alcohol-related liver disease with thioctic acid: a six month randomised double-blind trial. Gut. 23: 1088-93. PMID 6129179 DOI: 10.1136/Gut.23.12.1088 |
0.413 |
|
| 1981 |
Camilo ME, Morgan MY, Sherlock S. Erythrocyte transketolase activity in alcoholic liver disease. Scandinavian Journal of Gastroenterology. 16: 273-9. PMID 7313539 DOI: 10.3109/00365528109181968 |
0.403 |
|
| 1981 |
Katz A, Morgan MY, Sherlock S. Alcoholism treatment in a medical setting. Journal of Studies On Alcohol. 42: 136-43. PMID 7230811 DOI: 10.15288/Jsa.1981.42.136 |
0.401 |
|
| 1981 |
Morgan MY, Camilo ME, Luck W, Sherlock S, Hoffbrand AV. Macrocytosis in alcohol-related liver disease: its value for screening. Clinical and Laboratory Haematology. 3: 35-44. PMID 7226720 DOI: 10.1111/J.1365-2257.1981.Tb01307.X |
0.369 |
|
| 1981 |
Morgan MY, Colman JC, Sherlock S. The use of a combination of peripheral markers of diagnosing alcoholism and monitoring for continued abuse British Journal On Alcohol and Alcoholism. 16: 167-177. DOI: 10.1093/Oxfordjournals.Alcalc.A044288 |
0.367 |
|
| 1981 |
Morgan MY. Alcoholic liver disease: Its clinical diagnosis, evaluation and treatment British Journal On Alcohol and Alcoholism. 16: 62-77. DOI: 10.1093/Oxfordjournals.Alcalc.A044267 |
0.362 |
|
| 1980 |
Morgan MY, Ross MG, Ng CM, Adams DM, Thomas HC, Sherlock S. HLA-B8, immunoglobulins, and antibody responses in alcohol-related liver disease. Journal of Clinical Pathology. 33: 488-92. PMID 7400347 DOI: 10.1136/jcp.33.5.488 |
0.327 |
|
| 1980 |
Kirk AP, Vitale A, Morgan MY, Sherlock S. An epidemic of type B viral hepatitis: its course and outcome. Scandinavian Journal of Infectious Diseases. 12: 251-6. PMID 7006058 DOI: 10.3109/Inf.1980.12.Issue-4.03 |
0.378 |
|
| 1980 |
Morgan MY. Markers for detecting alcoholism and monitoring for continued abuse. Pharmacology, Biochemistry, and Behavior. 13: 1-8. PMID 6113598 DOI: 10.1016/S0091-3057(80)80002-5 |
0.33 |
|
| 1980 |
Colman JC, Morgan MY, Scheuer PJ, Sherlock S. Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trial. Gut. 21: 965-9. PMID 6108901 DOI: 10.1136/Gut.21.11.965 |
0.406 |
|
| 1980 |
Chapman RWG, Boss AMB, Morgan MY, Sherlock S. Iron Absorption in Alcoholic Liver Disease Clinical Science. 58. DOI: 10.1042/Cs058016P |
0.342 |
|
| 1979 |
Jakobovits AW, Morgan MY, Sherlock S. Hepatic siderosis in alcoholics. Digestive Diseases and Sciences. 24: 305-10. PMID 465138 DOI: 10.1007/Bf01296545 |
0.341 |
|
| 1978 |
Galizzi J, Morgan MY, Chitranukroh A, Sherlock S. The detection of minimal alcoholic liver disease by three methods. Scandinavian Journal of Gastroenterology. 13: 827-31. PMID 16683326 DOI: 10.3109/00365527809182198 |
0.426 |
|
| 1978 |
Morgan MY, Sherlock S, Scheuer PJ. Acute cholestasis, hepatic failure, and fatty liver in the alcoholic. Scandinavian Journal of Gastroenterology. 13: 299-303. PMID 755274 DOI: 10.3109/00365527809179824 |
0.445 |
|
| 1978 |
Morgan MY, Milsom JP, Sherlock S. Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut. 19: 1068-73. PMID 730076 |
0.327 |
|
| 1978 |
Morgan MY, Sherlock S, Scheuer PJ. Portal fibrosis in the livers of alcoholic patients. Gut. 19: 1015-21. PMID 730068 DOI: 10.1136/Gut.19.11.1015 |
0.406 |
|
| 1978 |
Morgan MY, Jakobovits AW, Gore MB, Wills MR, Sherlock S. Serum prolactin in liver disease and its relationship to gynaecomastia. Gut. 19: 170-4. PMID 631637 DOI: 10.1136/Gut.19.3.170 |
0.384 |
|
| 1977 |
Morgan MY, Jakobovits A, Elithorn A, James IM, Sherlock S. Successful use of bromocriptine in the treatment of a patient with chronic portasystemic encephalopathy. The New England Journal of Medicine. 296: 793-4. PMID 576493 DOI: 10.1056/Nejm197704072961406 |
0.347 |
|
| 1977 |
Morgan MY, Milsom JP, Sherlock S. Ratio of plasma alpha amino-n-butyric acid to leucine as an empirical marker of alcoholism: diagnostic value. Science (New York, N.Y.). 197: 1183-5. PMID 561441 DOI: 10.1126/Science.561441 |
0.353 |
|
| Show low-probability matches. |